November 30, 2015

Diverse Parties Say Federal Biotech Rules Confusing

Editor’s Note: The Framework is subject to the Data Quality Act including the requirement that federally-disseminated documents posess “utility.”  See here.

From: Bloomberg BNA/Chemical Reporter

By Pat Rizzuto

Nov. 27 — The federal approach to regulating bioengineered products is a confusing labyrinth, according to companies, trade associations, advocacy groups and scientists.


“Developers of products sometimes cannot easily ascertain whether potential products would be subject to regulations,” said the American Society of Plant Biologists, which joined nearly a thousand organizations and individuals that submitted comments on the Coordinated Framework for the Regulation of Biotechnology.

Read Complete Article

No Comments »

No comments yet.

Leave a Reply

Name not required for anonymous comments. Email is optional and will not be published.